Clinical trial · Observational
Enhancement of the Prediction of Chemotherapy Prescribing Errors for Oncology Patients
Cross-sectional Study to Enhance the Prediction of Prescribing Errors for Oncology Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
It is a cross-sectional study examining a random sample of in- and out-patients, with proven malignant disease receiving chemotherapy, over a period of 6 months from the start of the study who visit the Oncology department, Ain Shams University Teaching Hospitals. The effect of some risk factors on the prescribing error will be studied; these risk factors include the following: Tumor type ,Cancer stage ,type of comorbid illness ,type of medication , type of anti-cancer treatment , number of abnormal lab data ,type of abnormal lab data , the number of drugs in the treatment regimen , the number of side effects after chemotherapy administration, the age of patient ,the dosing frequency of anticancer ,the route of administration . Summary statistics are performed to describe patient characteristics , frequency, types and classification of medication error; and frequency with which Medication errors occur. Logistic regression will be applied to the collected data to perform a predictive relation between the risk factors which may be (categorical, continuous, or discrete) and the prescribing errors which are (categorical).
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Clinical Oncology | — | UNRESOLVED | — |
| Inappropriate Prescribing | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| determine the incidence , type , and severity of prescribing errors in the oncology department | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- patients with malignant cancer receiving chemotherapy
- description
- five hundred patients suffering malignant cancer from eight wards ( breast , GIT ,gynecological , genitourinary , lung , head and neck, lymphoma and myeloma ,skin and melanoma) ,receiving various chemotherapy protocols .
- interventionNames
- Behavioral: determine the incidence , type , and severity of prescribing errors in the oncology department
Primary outcomes (1)
- measure
- prescribing errors average
- timeFrame
- 6 months
- description
- to determine the average number of prescribing errors per patient
Secondary outcomes (1)
- measure
- cancer staging
- timeFrame
- 6 months
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * in- and out-patients, with proven malignant disease receiving chemotherapy Exclusion Criteria: * Patients receiving experimental agents and * patients who are too ill or unwilling to participate will be excluded.
References
Publications (0)
Data not yet available